Troy Ignelzi
Overview
Troy Ignelzi received an average of $3M in total compensation, including $394K in salary, at Karuna Therapeutics from 2019 to 2021. Troy Ignelzi also received an average of $669K at scPharmaceuticals from 2016 to 2019.
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
Karuna TherapeuticsChief Financial Officer
Karuna TherapeuticsChief Financial Officer
Karuna TherapeuticsChief Financial Officer
scPharmaceuticalsFormer Chief Financial Officer
scPharmaceuticalsFormer Chief Financial Officer
scPharmaceuticalsChief Financial Officer
scPharmaceuticalsChief Financial Officer
Source: SEC filings on April 27, 2022, April 27, 2021, April 29, 2020, April 27, 2020, April 30, 2019, and April 30, 2018.
Related executives
We found eight more executives who work or worked at Karuna Therapeutics and scPharmaceuticals.
John Tucker
scPharmaceuticals
Chief Executive Officer
Rachael Nokes
scPharmaceuticals
Chief Financial Officer
Steven Paul
Karuna Therapeutics
Chief Executive Officer
Andrew Miller
Karuna Therapeutics
Chief Operating Officer
Stephen Brannan
Karuna Therapeutics
Chief Medical Officer
Charmaine Lykins
Karuna Therapeutics
Chief Commercial Officer
Abraham Ceesay
scPharmaceuticals
Chief Operating Officer
Pieter Muntendam
scPharmaceuticals
Chief Executive Officer
News
Karuna Therapeutics CEO Steven Paul's 2021 pay jumps 48% to $13M
April 27, 2022
Karuna Therapeutics CEO Steven Paul's 2020 pay slips 11% to $8.9M
April 27, 2021
Karuna Therapeutics CEO Steven Paul's 2019 pay jumps 932% to $10M
April 29, 2020
scPharmaceuticals CEO John Tucker's 2019 pay slips 17% to $1.2M
April 27, 2020
scPharmaceuticals CEO John Tucker's 2018 pay falls 25% to $1.5M
April 30, 2019